Jon Hamilton
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
In 2014, Hamilton went to Liberia as part of the NPR team that covered Ebola. The team received a Peabody Award for its coverage.
Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.
Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans' social brains.
In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.
Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.
From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.
Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors. During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.
-
A new study finds that an HIV drug can reverse memory loss in aging mice. This type of memory helps humans do things like associate a name with a face. It typically starts to decline in middle age.
-
The memory of aging mice improved when they received a substance found in the spinal fluid of young animals and young people. The finding suggests a new approach to treating Alzheimer's disease.
-
Researchers say most brain scan studies are too small to explain complex human traits like intelligence or mental health. Meaningful insights will require studies of thousands of brains, not dozens.
-
NPR's Mary Louise Kelly talks with Dr. Wilbur Lam, a lead investigator assessing COVID-19 diagnostic tests for the U.S. government, about detecting the omicron BA.2 subvariant with rapid tests.
-
People who sustain a concussion can develop an unusual hearing problem. Their ears work fine, but their brain struggles to process sounds. (Story first aired on All Things Considered on Nov. 3, 2021.)
-
Medicare officials announced on Thursday that the health insurance program for older Americans will sharply limit coverage of a costly and controversial new Alzheimer's drug.
-
A study of more than 120,000 brain scans shows rapid growth before age 2 and accelerating decline after age 50. The results may one day help pick up abnormalities in the developing brain. -
Scientists are trying to understand PTSD and other human disorders by studying emotion-related brain circuits in animals, which research suggests may have a lot in common with the human brain.
-
Mild cognitive impairment, a condition that may be a precursor to Alzheimer's disease, affects more than 12% of people 60 and up. Yet a survey found 82% of Americans know little or nothing about it.
-
Some parents have argued that masks need to come off in schools because it affects kids' speech and social development. Is that really true? Researchers address this question from several angles.
